Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with
few systemic side effects. In addition, it is non-invasive and has good patient compliance …

As severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants continue to
wreak havoc worldwide, the “Cytokine Storm”(CS, also known as the inflammatory storm) or …

Pulmonary delivery of protein-based therapeutics, including antibodies, is a promising
option for treating respiratory diseases. Spray drying is a widely used method for producing …

The purpose of our research is to develop functional additives that enhance mucosal
absorption of biologics, such as peptide/protein and antibody drugs, to provide their non-to …

The authors want to acknowledge the AAPS Communities to providing a space for the DP
Handling Community that encouraged the writing of this paper. We also want to …

The use of natural pulmonary surfactants (PS) as a drug delivery vehicle for biologics is a
more recent therapeutic modality. Herein, we tested different contents of PS regarding their …

Limited attempts have been made previously to develop high-loading CBD inhalable
powders, which are essential for high dose delivery. Therefore, this study aimed to develop …

Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by acute
hypoxemic respiratory failure. Pneumonia and sepsis are the most common causes, turning …

It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …

Protein‐based therapeutics and vaccines play a pivotal role in the realm of biomedical
science. Pulmonary administration offers several advantages including rapid adsorption …